Jubilant Biosys Limited ("Biosys"), a wholly owned subsidiary of Jubilant 
Life Sciences Limited, today announced completion of the merger with its sister 
company Jubilant Chemsys Limited, based in Noida, India. The combined entities 
will now operate as Jubilant Biosys Limited.

    The merger will simplify operations and provide customers with a single 
brand access for a wide range of discovery, IND and PR&D and GMP development 
services. Biosys had earlier announced significant investment in building new 
state-of-the-art research facilities in Greater Noida and in Bengaluru, India 
to cater to increasing customer demand for its functional services (medicinal & 
synthetic chemistry, structural biology, DMPK, Biology & GMP scale-up) and 
notably integrated drug discovery services.

    Marcel Velterop, President- Jubilant Biosys Limited and CDMO, said: "We are 
delighted to make this merger happen and focus our investments for growth to 
expand both the chemistry as well as integrated drug discovery capabilities. It 
provides clarity to customers and enables us to better deliver on our '4D' 
promise of accelerating the discovery process through increased digitization of 
our operations and information flow."

    About Jubilant Biosys Limited:

    Jubilant Biosys, a Bengaluru based wholly owned subsidiary of Jubilant Life 
Sciences Ltd, offers contract research & development services for global 
pharmaceutical innovators. Biosys has demonstrated expertise in functional 
services such as Biology, DMPK, Toxicology as well as Medicinal Chemistry, PR&D 
and GMP scale-up capabilities up to phase II. It has a proven track record of 
delivering over 75 integrated programs in multiple therapeutic areas including 
but not limited to Oncology, Metabolic Disorders, Pain & Inflammation, CNS and 
expanding into Rare Diseases. Its sister company, TrialStat Solution Inc., 
provides an advanced EDC platform to accelerate clinical trials' data capture 
and processing. For more info, please visit www.jubilantbiosys.com.

    Logo: https://mma.prnewswire.com/media/821405/Jubilant_Biosys_Logo.jpg

    Source: Jubilant Biosys Limited